A shortened activated partial thromboplastin time predicts thromboembolic risk in patients with newly diagnosed multiple myeloma

被引：0
|
作者：
Carter, A. [1 ]
Rossini, F. [1 ]
Borella, C. [1 ]
Coccini, V [1 ]
Cammarota, S. [1 ]
Rossi, F. [2 ]
Poghani, E. M. [1 ]
机构：
[1] Milano Bicocca Univ, Osped S Gerardo, Hematol & Bone Marrow Transplant Unit, Monza, Italy
[2] Milano Bicocca Univ, Osped S Gerardo, Immunotransfus Serv, Monza, Italy
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2007年 / 92卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：136 / 136
页数：1
相关论文
共 50 条
  • [1] The Prognostic Role of Prothrombin Time and Activated Partial Thromboplastin Time in Patients with Newly Diagnosed Multiple Myeloma
    Geng, Chuanying
    Yang, Guangzhong
    Wang, Huijuan
    Zhang, Zhiyao
    Zhou, Huixing
    Chen, Wenming
    BIOMED RESEARCH INTERNATIONAL, 2021, 2021
  • [2] A shortened activated partial thromboplastin time predicts the risk of catheter-associated venous thrombosis in cancer patients
    Senthil, Maheswari
    Chaudhary, Preeti
    Smith, David D.
    Ventura, Patrick E.
    Frankel, Paul H.
    Pullarkat, Vinod
    Trisal, Vijay
    THROMBOSIS RESEARCH, 2014, 134 (01) : 165 - 168
  • [3] A shortened activated partial thromboplastin time is associated with the risk of venous thromboembolism
    Tripodi, A
    Chantarangkul, V
    Martinelli, I
    Bucciarelli, P
    Mannucci, PM
    BLOOD, 2004, 104 (12) : 3631 - 3634
  • [4] Shortened activated partial thromboplastin time: causes and management
    Lippi, Giuseppe
    Salvagno, Gian Luca
    Ippolito, Luigi
    Franchini, Massimo
    Favaloro, Emmanuel J.
    BLOOD COAGULATION & FIBRINOLYSIS, 2010, 21 (05) : 459 - 463
  • [5] SHORTENED ACTIVATED PARTIAL THROMBOPLASTIN TIME IN PATIENTS WITH CEREBRAL-DAMAGE - A PROGNOSTIC FACTOR
    TURNER, GA
    TWEEDDALE, MG
    CRITICAL CARE MEDICINE, 1981, 9 (03) : 246 - 246
  • [6] The clinical significance of a shortened activated partial thromboplastin time in patients with connective tissue disease
    Habe, Koji
    Wada, Hideo
    Mizutani, Kento
    Matsushima, Yoshiaki
    Kondo, Makoto
    Yamanaka, Keiichi
    CLINICAL RHEUMATOLOGY, 2021, 40 (11) : 4675 - 4683
  • [7] The clinical significance of a shortened activated partial thromboplastin time in patients with connective tissue disease
    Koji Habe
    Hideo Wada
    Kento Mizutani
    Yoshiaki Matsushima
    Makoto Kondo
    Keiichi Yamanaka
    Clinical Rheumatology, 2021, 40 : 4675 - 4683
  • [8] Hematopoietic score predicts outcomes in newly diagnosed multiple myeloma patients
    Al Saleh, Abdullah S.
    Sidiqi, M. Hasib
    Dispenzieri, Angela
    Kapoor, Prashant
    Muchtar, Eli
    Buadi, Francis K.
    Warsame, Rahma
    Lacy, Martha Q.
    Dingli, David
    Leung, Nelson
    Gonsalves, Wilson I.
    Kourelis, Taxiarchis V.
    Gertz, Morie A.
    Go, Ronald S.
    Kyle, Robert A.
    Rajkumar, S. Vincent
    Kumar, Shaji K.
    AMERICAN JOURNAL OF HEMATOLOGY, 2020, 95 (01) : 4 - 9
  • [9] Thromboembolic risk factors in patients undergoing kidney transplant: Implication of abnormally short activated partial thromboplastin time
    Guirguis, NG
    Eicher, C
    Hock, L
    Lynch, J
    Graham, VD
    Rajagopalan, PR
    Guirguis, A
    Lazarchick, J
    ANNALS OF CLINICAL AND LABORATORY SCIENCE, 2003, 33 (04): : 396 - 400
  • [10] Risk of Early Mortality in Patients With Newly Diagnosed Multiple Myeloma
    Hsu, Pei
    Lin, Ting-Wei
    Gau, Jyh-Pyng
    Yu, Yuan-Bin
    Hsiao, Liang-Tsai
    Tzeng, Cheng-Hwai
    Chen, Po-Min
    Chiou, Tzeon-Jye
    Liu, Jin-Hwang
    Liu, Yao-Chung
    Liu, Chia-Jen
    MEDICINE, 2015, 94 (50)
12345